Antimicrobial resistance (AMR) poses a significant threat to the health of all humankind, with potentially devastating economic consequences. In 2015, the World Health Organization (WHO)

Telum Therapeutics announced today the appointment of Professor Vincent A. Fischetti, that has introduced phage lysins as a new antimicrobial therapy and an alternative to

The concentrations of antibiotic residues found in wastewater and wastewater treatment plants of the WHO Western Pacific region (WPR) and the South-East Asia region (SEAR)